CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 100 enrolled
Drug / intervention
Bupivacaine Hydrochloride 0.25% Injection Solutiondrug
Likely dose
Bupivacaine Hydrochloride 0.25% Injection Solution 10 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03283436
NCT03283436Phase 4Completed
CompareCT.gov

Superior Hypogastric Plexus Block During Laparoscopic Hysterectomy: a Randomized Controlled Trial.

Jon I. Einarsson·interventional·Posted Sep 14, 2017·Updated Oct 27, 2020

In Brief

A Phase 4 clinical trial evaluating Bupivacaine Hydrochloride 0.25% Injection Solution for Hysterectomy. Completed, enrolled 100 participants across 2 sites.

Detailed Summary

The goal of this study is to assess the efficacy of a superior hypogastric plexus block (SHPB) for pain relief following a laparoscopic hysterectomy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHysterectomy
CountriesUnited States
CollaboratorsUniversity of North Carolina, George Washington University

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedSep 14, 2017
Enrollment StartJan 18, 2018
Primary CompletionFeb 21, 2019
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 8.8 years ago

Interventions

Bupivacaine Hydrochloride 0.25% Injection Solutiondrug

10 mL of 0.25% bupivacaine hydrochloride (2.5 mg/mL = 25 mg)